G

General Atlantic

Global growth investor with value-added support

Life Sciences Associate

Full-Time
$150k - $160k/yr+ Annual discretionary bonuses + Long-term incentive programs
Junior, Mid, Senior
PhD, MD
New York, NY, USA
In PersonOn-site in New York, New York; remote work not indicated.

About the job

Requirements
  • MD or PhD in relevant scientific field (molecular biology, genetics, biology, chemistry, etc.)
  • 2-5 years of post-graduate school professional experience, including at least 2 years of relevant experience in the life sciences sector (e.g., life sciences investing, life sciences strategy consulting, life sciences equity research / investment banking, biopharma operating role)
  • Ability to analyze and integrate data from various sources into investment recommendations, including preclinical and clinical data, FDA/regulatory correspondence, and market research
  • Strong foundation in financial modeling with a demonstrated commitment to deepening analytical expertise
  • Passion for primary scientific literature, including scientific/medical meetings and conferences
  • High degree of familiarity with drug development and regulatory processes
  • Excellent written and verbal communication skills, with the ability to synthesize and present complex information clearly
  • Demonstrated maturity and professional presence; comfortable interacting with senior executives and management teams
  • Highly motivated, inquisitive, and a positive, can-do attitude
  • Ability to take ownership, work independently, manage multiple priorities, and thrive in a fast-paced, entrepreneurial environment
Responsibilities
  • Source, evaluate, and recommend investment opportunities in drug development / biopharmaceutical companies including development and ownership of thematic focus areas
  • Support scientific and clinical due diligence, integrating preclinical data, clinical trial results, regulatory strategy, and market dynamics into investment recommendations
  • Develop and present rigorous investment theses to senior stakeholders, including the global Investment Committee
  • Contribute across the full deal process, including coordination of third-party scientific advisors, KOLs, and commercial consultants
  • Monitor portfolio companies and support the GA team’s efforts in capital allocation and value creation
  • Leverage clinical and industry networks to generate proprietary deal flow and market intelligence
  • Collaborate with professionals across the firm and foster exceptional knowledge-sharing

About the company

General Atlantic partners with high-quality growth companies worldwide, providing strategic and operational value-added support to help portfolio companies become market leaders and build long-term shareholder value. As a growth investor, it uses a collaborative, global approach with sector-specific expertise and macroeconomic growth insight to guide investments. Its team combines investment professionals with a Resources Group and Special Advisors to access a broad network and deliver integrated, customized support across regions and industries. The firm differentiates itself through hands-on collaboration, sector and regional know-how, and a track record of helping management teams scale businesses over time, aiming to achieve lasting leadership in their markets.

Company Size

501-1,000

Company Stage

N/A

Total Funding

$93B

Headquarters

New York City, New York

Founded

1980

Get referred to General Atlantic

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AUM reached $130 billion by June 30, 2026, supporting larger fee pools.
  • GA closed Chariot Re's $700 million raise on September 2, 2026.
  • SambaNova and Blank Street financings in 2026 prove active deployment into hot sectors.

What critics are saying

  • King v. General Atlantic Service Company entered federal court on September 30, 2026.
  • Deutsche Börse bought GA's remaining ISS STOXX stake, removing a proven monetization engine.
  • A prolonged 2026 IPO drought traps GA's portfolio, crushing realizations and future fundraising.

What makes General Atlantic unique

  • GA spans Growth Equity, Credit, Energy Transition, and Infrastructure across 21 locations.
  • Its May 11, 2026 QIA partnership added $500 million and Middle East market access.
  • The September 1, 2026 625 Madison lease signals scale, permanence, and employer brand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Mental Health Support

Performance Bonus

Company News

CARE for Pets
Oct 2nd, 2026
GoodVets Acquires WellHaven Pet Health, adds 40+ veterinary hospitals.

GoodVets Acquires WellHaven Pet Health, adds 40+ veterinary hospitals. October 2, 2026 Admin GoodVets, recently ANNOUNCED that it has acquired WellHaven Pet Health (WellHaven), a network of over 40 veterinary hospitals operating across seven states. The transaction expands GoodVets' network from 75 to 116 hospitals and extends its presence across key regions in the United States, including the Pacific Northwest and Midwest. Financial terms of the transaction were not disclosed. Over time, each WellHaven hospital will transition to the GoodVets brand. * GoodVets Expands Its Relationship-Based Veterinary Care Model with WellHaven Pet Health (9.24.26) https://www.businesswire.com/news/home/20260924180902/en/GoodVets-Expands-Its-Relationship-Based-Veterinary-Care-Model-with-WellHaven-Pet-Health * GoodVets Acquires WellHaven Pet Health (9.24.26) https://www.martiscapital.com/goodvets-acquires-wellhaven-pet-health/ * Martis Captial founded WellHaven (Investment Date: July 2017) starting with a single hospital in Portland, Oregon, and supported the company's growth into a leading multi-regional veterinary platform. * GoodVets Announces Strategic Growth Investment from General Atlantic to Fuel Continued Expansion of Leading Veterinary Care Platform (9.13.23) https://www.businesswire.com/news/home/20230913197524/en/GoodVets-Announces-Strategic-Growth-Investment-from-General-Atlantic-to-Fuel-Continued-Expansion-of-Leading-Veterinary-Care-Platform * GoodVets announced it has received a strategic growth investment from General Atlantic, a leading global growth equity firm. General Atlantic joins existing investor SkyKnight Capital, L.P. ("SkyKnight"). * GoodVets Group Partners with SkyKnight Capital to Accelerate Growth and Build Leading, Modern Veterinary Care Platform (7.12.21) https://www.businesswire.com/news/home/20210712005207/en/GoodVets-Group-Partners-with-SkyKnight-Capital-to-Accelerate-Growth-and-Build-Leading-Modern-Veterinary-Care-Platform * SkyKnight Capital, L.P. ("SkyKnight"), a private equity firm, announced that it has made a growth investment into GoodVets Group LLC.

Devo
Sep 27th, 2026
Devo Announces $250 Million Funding Round Led by TCV

Devo announces $250M funding round led by TCV, catapulting surging cloud-native logging and security analytics leader to $1.5B valuation.

JumpCloud
Sep 19th, 2026
JumpCloud® Partners with General Atlantic for Significant Investment Round

JumpCloud is pleased to announce that it has partnered with General Atlantic (GA) on its most recent round of financing.

Greylock Partners
Sep 18th, 2026
Anthropic | Greylock

AI research and products that put safety at the frontier.

General Atlantic
Sep 15th, 2026
Melis Kahya Akar recognized in Private Equity News' Twenty Trailblazing Women 2026 list.

Melis Kahya Akar recognized in Private Equity News' Twenty Trailblazing Women 2026 list. September 15, 2026 Melis Kahya Akar, Managing Director and Head of Consumer EMEA at General Atlantic, has been recognized in Private Equity News' Twenty Trailblazing Women 2026 list for the third consecutive year. Melis leads General Atlantic's consumer investments across EMEA, as well as its activity in Turkey. Over the past two years, she has spearheaded investments including global fragrance house KAYALI and direct-to-consumer eyewear retailer eyewa. She currently serves on several boards including Butternut Box, Gymshark, and Joe & the Juice. Private Equity News' Twenty Trailblazing Women list recognizes leading women across European private equity investing and fundraising for their impact on the industry and efforts to support the next generation of female leaders.